← All research updates

How glioblastoma recruits more immune cells to help it grow

Original title: Microglia-derived Small Extracellular Vesicles Promote Bone Marrow Monocyte Expansion and Recruitment in Glioblastoma.

How far along is this research?

This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.

This is early lab research into how the disease works, not a treatment.

The short version

Lab work shows one way glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary turns the body's own immune cells against it.

What was studied. Scientists studied tiny bubbles released by immune cells that sit inside glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary tumors. These cells are called microglia. The team followed where the bubbles went and what they did.

What they found. The bubbles traveled to the bone marrow. There they homed in on a kind of white blood cell called a monocyte, and the cells that make them. Inside those cells, the bubbles switched on signals that made more monocytes. Those new cells were then pulled into the tumor, where they helped hold the immune system back.

What this means, and what it doesn't

What it could mean: This points to one reason the immune system has a hard time fighting glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary. If this signal can be blocked, it might help the immune system do more. That has not been tested in people.

What it doesn't mean: This is not a new treatment. It is early lab research about how the disease works, not a trial in patients. There is no drug here you can ask your doctor for. It is not a cure, and it does not change care today.

Source: bioRxiv (preprint), October 14, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary